MedPath

Group Cognitive Behavioral Therapy for Irritable Bowel Syndrome A Cost-Utility Analysis: Results from a Randomized Controlled Trial

Not Applicable
Conditions
Irritable Bowel Syndrome
Registration Number
JPRN-UMIN000048267
Lead Sponsor
Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
114
Inclusion Criteria

Not provided

Exclusion Criteria

Have received or are receiving other structured psychotherapy at the time of the baseline assessment Currently receiving psychiatric or psychosomatic treatment and deemed by the attending psychiatrist or psychosomatic physician to be ineligible for participation in this study. Patients who meet the diagnostic criteria for major depression on the Patient Health Questionnaire-9 (PHQ-9) at the baseline assessment, or who have had "more than half of the time in two weeks" of suicidal thoughts on item 9 of the PHQ-9. Pregnant women Participants who have been treated or are being treated for organic diseases Other participants who are judged by the principal investigator or research assistant investigator to be inappropriate as subjects of this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EQ-5D-5
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath